drugset / Trial / NCT00830427
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
This study (A7881006) is the first multiple dose study in moderate asthmatic subjects and aims to determine the safety and efficacy of PF-00610355 when subjects take PF-00610355 on a daily basis for 4 weeks in subjects maintained on inhaled corticosteroid.
Timeline
- Start
- 2009-04-15
- Primary completion
- 2009-12-31
- Completion
- 2009-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00610355 | Small molecule | 100 ug | Inhaled |
| Subject | PF-00610355 | Small molecule | 300 ug | Inhaled |
| Subject | PF-00610355 | Small molecule | 600 ug | Inhaled |